Read “What to expect at the 2023 MM+M Media Summit” here.
In a preview of their session at this week’s MM+M Media Summit, Jack O’Brien interviews Roku’s Chris Schneider about how pharma brands can ride the ad-supported streaming wave. Lecia Bushak explains the FTC’s recent crackdown on pharma companies over incorrectly listing patents in the FDA’s “Orange book.” And TikTok’s skincare craze tops our Trends segment, along with the reason for Brook Shields’ recent seizure and a newly launched cancer research fund named after Alex Trebek.
Note: The MM+M Podcast uses speech-recognition software to generate transcripts, which may contain errors. Please use the transcript as a tool but check the corresponding audio before quoting the podcast.
Hey, it’s Marc.
The pandemic provided a huge tailwind for the pharma industry to digitize advertising.
As streamed video content became an everyday part of most viewers’ lives, it was only logical that pharma brands would need to continue reaching them.
While many brands have scaled back those COVID-era digital media investments, the use of channels like search, display and Connected TV by brands to reach audiences remains historically high.
MM+M’s own data show that last year, video in particular – which includes programmatic and CTV – was one of the fastest-growing channels on both sides of the audience mix, both HCP and consumer.
Yet, pharma’s digital ad wallet is a volatile and nascent thing. Proponents of Over-the-Top media often need to make the case all over again.
That’s where Chris Schneider comes in. Schneider is Roku’s health and wellness marketing lead.
And Jack – with MM+M’s annual Media Summit coming up this Wednesday, Nov. 8 – you interviewed Chris (who’s actually speaking at the event) for a preview of his talk, especially about bolstering relationships with change-wary pharma marketers, right?
Yeah. We had a chance to talk earlier and it was a great.
Conversation he’s obviously very excited for the panel and getting to talk about some of the digital health and marketing trends that he’s been paying attention to and obviously how the streaming sector is evolving with different platforms the emergence of AD supported tiers and all these different options that brands have to be able to get in front of different targeted Niche consumer audiences. So it was a great conversation. I really look forward to having our listeners not only hear the conversation but then be able to hear his insights at the media Summit on Wednesday,
excellent and he’s you know, not only a disciple of streaming but he’s sitting on a lot of really interesting learning. So that’s a really interesting conversation.
And Lecia returns with her health policy update…
Hey Marc, today I’ll break down the Federal Trade Commission’s recent effort to crack down on pharma companies when they don’t correctly list patents in the FDA’s “Orange book.”
And finally, Jack, what’s trending in healthcare this week?
This week, we’re talking about Brooke Shields having a seizure after drinking too much water, TikTok’s skincare obsession and the launch of the Alex Trebek fund.
A marquisco it’s editor at large and welcome to the mmm podcast medical marketing media show about Healthcare marketing writ large.
Chris great great to have you on the show super pumped to be here really looking forward to our panel this week. Yeah, we’re glad to have you on
here to preview the media Summit. Obviously. We’re excited to be hosting our second annual one on Wednesday, November 8th. Tell me a little bit about what you’re most looking forward to and that we can hop into the panel that you would just mentioned. Yeah. Sure.
So I’m really excited to be up there on the stage with my colleagues from Samsung pulse point and Bristol-Myers squib. I think we’re gonna give the audience some really solid pieces of information to think about and when they leave that day, hopefully something to take action upon. So we love bringing up actionable insights and really, you know, the title of this panel the streaming revolutions first hiccup is something that we’re really all excited to talk about. I think that
When you think about where Pharma is in general, it’s it’s an exciting time to be in the streaming ecosystem. And I think we’ll talk about a few major themes. If you want me to kind of go into some of those.
I think that’d be really helpful for our audience because I think they look at everything that’s taking place in the streaming sector right now and they say, oh we have you know, opportunities Galore, but we’re trying to Target our messaging to specific patients and we want to get certain brands and in different areas. Is that stuff that you’re gonna be focusing on or is it gonna be a little
different? Yeah, totally. I mean, I think we’re gonna we’re gonna talk about I think three major themes where we are as a farm industry with, you know, streaming advertising adoption streaming macro Trends and the consumer experience and then I think finally strategies for how farm and marketers can really make streaming work for their brand. So to kind of touch on what you said, you know how CTV can can show up differently for different brands whether it’s
Ran with a smaller Niche indication or a brand that needs, you know, really large scale awareness driving
tactics when you look at the connected TV landscape right now, maybe what are some of the more misunderstood aspects of it? Because I always see campaigns that launch and they say, you know, we have a connected TV angle. I talked to a lot of marketers and they understand the importance of it. But you know, it’s not just that you find yourself on connected TV. There has to be a strategy and a goal and metrics that you’re following. What is probably the most misunderstood aspect of
actually getting into that space. Yeah. I’m super excited. You ask me that question because I think a big part of my role at Roku is really around myth busting and so one of the things that we’ve talked a lot about in the industry with clients with agencies is around some of these aspects that are misunderstood. So one of the ones we talked about earlier last year was around cord cutters. So when you think about Roku and our place
Streaming ecosystem. We’re America’s number one streaming platform by our stream. We have 75 million active accounts and 64% of those accounts are cordless. Meaning they don’t have access to linear TV. And so when you think about that,
It aligns with the overall macro where Nielsen said that over 50% of homes in the US don’t have pay TV. So when you think about cord cutters, these are potentially large parts or large audiences that aren’t seeing messages in a hundred percent non-skippable format on the largest screen in the home. And so we work with Lucid last year to kind of quantify that and we we wanted to look at the Gap in Awareness across Pharma Brands between cord cutters and linear viewers and what we found for that cord cutters were 35% less aware of the top advertised Pharma Brands than linear TV consumers. And so that has massive implications on public health.
And so that’s one myth that we look to Boston and we also looked at hcps too. And we found that primary care physicians who are cord cutters were 14% less aware of the top advertised Brands as well. And so when you think about the overall scale of streaming a lot of Brands will think of streaming as incremental to linear.
And that’s a great strategy. But what they’re not realizing is there is the scale to get that broad awareness that you’re going for. So whether it’s broad awareness that you’re looking for or whether you’re trying to reach a more Niche audience that’s an aspect of CTV that Brands can really capitalize on
and can you talk about both from the patient the hcp perspective the downstream effects of not having that brand awareness with Target audiences because I’ve seen a lot of studies and I’ve talked to different leaders who say that you know, it’s not just the fact that oh, maybe they don’t necessarily know your brand as well. It’s really if there’s a product that you’re trying to get into a patient population that has a certain condition or disease State and they’re not able to hear that messaging that impacts their health down the line that can have that trental effects the same way that you talk about if a primary care physician who is writing those prescriptions or is taking care of these patient populations if they’re not interacting with your brand or your drug. That means that that’s not getting prescribed to that audience. You want to be a part of
Totally and that’s such a great point because really why do we advertise we advertise in all Industries to connect brands with the consumer and for Pharma? There’s a patient on the end of that advertising.
That if they don’t understand the brand messaging if they don’t understand the benefits to them, they’re not going to ask their doctor and they’re not going to potentially receive treatment that could really benefit their lives. And so it’s an important aspect and you know advertising really is that bridge?
That helps to get people on medication it helps to speed the time from innovation in the lab to a patient taking a medication.
I’m curious your thoughts from a brand
perspective. Obviously. We’re in this kind of New Media landscape where obviously yes, we have a lot of cord cutters and so cable As We Knew It 15 to 20 years ago is not the same thing. We’ve moved into a really streaming focused Arrow, whether you have some combination of Netflix Hulu Disney plus you name it in terms of your offerings Roku certainly, but that makes it harder than to get in front of certain Target audiences. The price of streaming has gone up which I know a lot of people are either, you know, getting their login from somebody else or they’re just certainly they’re just not doing streaming anymore. How is that complicated the equation where it’s not just well if you’re not on cable you’re on streaming, but now if you’re not on streaming, where is that audience? How do you get that message out there?
Yeah. Sure. So I think really the hiccup is that going ad free is getting harder for the consumer as the price between, you know, ad free and AD supported widens and the macro economy strain. So you mention the wallet getting bigger for consumers you
the growth of streaming is is still up into the right and but the future the real Winner Is In AD supported and this is a huge opportunity for advertisers because you know, even if the total streaming hours were to let’s say decline the number of AD supported streaming hours as part of that pie is likely to rise which
ultimately is a great opportunity for advertisers who are looking to get in front of consumers on that premium inventory. And so
What you’ll see is either one of two things happen, you’ll see ad supported rise or you’ll see churn across apps. And so that presents a challenge for advertisers because a consumer that is going to turn
Could be you know in one app at the beginning of the year, but then not in that app at the end of the year. So as an Advertiser what we tell people is to buy the platform not the pieces.
And that’s because if you work with a platform that has scale you’re able to reach a streamer no matter where they are in the ad supported ecosystem whether it’s on the Roku Channel or if it’s on one of the hundred ad supported apps that are out there you’re able to reach that streamer
across their Journey just to clarify on that too. So you’re talking about like say if I started 2024 and I had Netflix and then Netflix raises the price and I decided to go to Paramount Plus or someplace else where I feel like I’m gonna have a better experience at a better price points that we’re kind of referring to so basically,
When you think about churn a person that is a Serial Turner is kind of the modern era channel changer, right? So they’re going to start in one app cancel and then resign up or maybe not resign up at all. And so that creates headaches for advertisers that are buying on a channel by Channel level because the consumer that starts the year in one app may not be the same consumer that ends the year on that app. And so that’s why we say by the platform not the pieces because when you work with a platform with scale you’re able to you know, find the audience regardless of the content across their streamers Journey. So with Roku, we have our own and operated Channel called the Roku Channel and then we have access to inventory across the top 100 AD supported apps that are out there and so wherever
That audience that you’re trying to find spends time that’s where we’re able to then align
your ad spot to.
Have there been any sort of conversations Chris, you know, whether internally or when you’re talking with brands that are trying to average what advertise in your platform about the potential for Burnout or consumers being like, you know, I remember when Netflix was you know, ad free. I remember when X platform was ad free and I didn’t have to you know, I pause my TV now and I see an ad there like, is there any potential there where it’s like, yeah, there’s more opportunity for Brands but maybe consumers have changed in terms of how they receive the message or is that something that’s not top of mind? No, it’s a great question and I think that
The one thing to remember is that stream will have half the ad load of traditional linear TV. So when you think of that experience, that’s a positive for consumers. I do think that discoverability is a major issue and to put that into context right now globally, there’s 2.5 million pieces of unique content and it takes a streamer 10 and a half minutes to find what they want to watch. That’s up from seven minutes in 2019.
So that is Major and when you think about consumers, you know broader than that, there’s an additional like 20% of consumers that just turn on the TV and have no concept of what they want to watch and that’s all according to Nielsen’s gauge report.
And so discoverability is definitely a challenge and that’s where Roku which really serves as the gateway to the streaming experience can help be a positive impact there.
Roku can help Brands to be a part of the solution because
We can help.
Align Brands to help audiences discover content and what I mean by that is that we can curate content and promote it on our platform. So
To put that even into further context. Let’s say you’re a diabetes brand we could curate a Content playlist for your brand to sponsor like healthy cooking.
And our Roku brand Studio could even take it a step further to actually create a cooking show that your brand can surround and this really builds trust with streamers and really helps them to solve that problem of discoverability. And if you have a Roku device, you’ll know that on the left hand side, you have different zones and a search functionality and in the middle, you have all the apps that you can personalize and upload on the right hand side is what we call our Marquee which takes up a third of the screen and that’s really where we can promote content to certain audiences. And that’s where we generate a lot of our sponsorships from
I appreciate you detailing what Roku is able to do in this space. I know that a lot of other competitors are taking similar approaches as they try and work through a fragmented media landscape when you look at media Dynamics in the healthcare space now, what are you most optimistic about in terms of changes, obviously?
We saw a lot of different approaches to advertising through covid as more people went online. And that’s where their world is. I know there’s been a renewed focus on digital and certainly an interest in Ai and what that can mean for advertising but what are what really gets you going in terms of like, okay, we’re kind of moving in the right direction as an industry. We’re engaging with the consumer in ways that we haven’t before.
Yeah. I think it’s working with clients and
when you work with clients and you zoom out even further you can kind of think about the Pharma industry in terms of that relationship with linear and streaming and you know in 2022 meteor radar mentioned that
Um Pharma spent 65% of their ad dollars on linear television and they’re missing audiences which which we talked about but we’re starting to see Brands test and learn we’re starting to see a majority of brand scale.
And then we’re we have some brands that are really leaning in on streaming. And so that growth is is going you know up into the right and ultimately that
benefits the patients on the end and it benefits us being able to connect with with consumers in new and unique ways. And I think one of the things that is really exciting to me is the fact that
CTV makes every brand a TV brand.
and why I say that is because
you can connect with a small audience on CTV because of the target ability or a broader audience. And so that opens up the mix for some of these brands that are approved with a narrow audience.
So across the FDA approvals, if you look each year, there’s an average of 45 brands that are approved more and more. These brands are Niche. And so the fact that they might they may not have ever thought of themselves as a TV brand right that might not have been a part of their identity. But because of this channel that identity can change for them and it’s a new way for them to engage with patients. I
appreciate you going through what makes you optimistic on the media landscape front. I want to ask you conversely where you may be see room for improvement maybe in terms either of approaches to advertising when you’re talking with brands or maybe what you even like to see streaming take a different approach going forward. I think there’s a notion
within Pharma that everyone wants to be Innovative, but they want it to be done once before and it’s because of the medical legal review process and how it’s it’s challenge.
And you know, I’d love to see Brands take more risks and and explore, you know, the different ad products that are out there within the streaming ecosystem.
We see a lot of video. We do see sponsorships, but
Brands need to really think about how they can.
Heavy up on sponsorships to connect with consumers in new ways.
We know that when Brands work with the consumer at a new level. It drives Trust.
And we saw through survey that.
driving Trust
makes people want to try new medications. And so I think it comes down to like how can you build flexibility into your process as a marketer on the brand side to really lean into these new opportunities that streaming presents. I think a little flexibility
would go a long way like you said in terms of both streaming and in terms of how Brands decide to advertise to their target consumers, I’ve really enjoyed having you on the show here Chris obviously very excited to see you in person on Wednesday and hear your insights want to see if there is anything else you want to share to the audience that would get them excited and tune into the media Summit on Wednesday. It’s a great panel, you know, we have really good
representation from the streaming ecosystem and third party dsps and also client. So we’re gonna get a really good Collective group on the stage to talk through the ways that Brands can really lean into the streaming era so super excited to work with you.
And M&M and detail all these things. Awesome. Well, thank you. Again Chris. Really? Appreciate you sharing
your insights and look forward to seeing you on Wednesday.
Thanks Jack.
Health Policy update with Lecia Bushak.
The Federal Trade Commission has been on a spree lately cracking down on the pharma and healthcare industry – from targeting major mergers and acquisitions, to launching inquiries into pharmacy benefit managers – as the national scrutiny on high drug prices remains top of mind.
Now, the FTC is doubling down on pharma companies that improperly list patents for drugs in the Food and Drug Administration’s registry for patents, known as the “Orange Book.”
In September, the FTC rolled out a policy statement that targets QUOTE “sham patents” in the Orange Book.
A patent in the Orange Book can prevent generic drugs from entering the market for up to 30 months. Pharma companies that list sham patents are doing so to stifle competition and keep drug prices high, the FTC argued.
FTC Chair Lina Khan noted in a statement that QUOTE “Improper patent listings in the Orange Book illegitimately delay or lock out generic manufacturers from entering the market, depriving Americans of access to lower-cost medicines and drug products.”
She added that “We won’t hesitate to use all our tools to combat illegal practices that are inflating the price of healthcare, including medicines.”
The FTC’s move followed calls from lawmakers to address the issue, including Senator Elizabeth Warren, who called on the FDA to tighten guidelines on it. The FTC has been eyeing the issue for more than two decades now, since in 2002 it released its “first complaint” against Biovail Corporation for wrongfully acquiring a patent license for blood pressure drug Tiazac.
The FTC said that pharma companies could face legal action if they choose to improperly list patents moving forward. I’m Lecia Bushak, Senior Reporter at MM+M.
And this is the part of the broadcast when we welcome Jack O’Brien to tell us what’s trending on healthcare social media.
Hey Marc, a couple of stories just missed the cut, including a TikTok interview that’s generated interest since it appears to feature a woman claiming to be ‘Pharma Bro’ Martin Shkreli’s girlfriend as well as Buffalo Bills safety returning to Cincinnati about 10 months after suffering cardiac arrest to surprise the emergency personnel who saved his life with scholarships named after each of them.
We start today with Brook Shields’ recent health scare due to drinking too much water.
The Hollywood star told Glamor in an interview that she suffered a full-blown grand mal seizure before the recent Glamour Woman of the Year show.
She said: “I was preparing for the show, and I was drinking so much water, and I didn’t know I was low in sodium. I was waiting for an Uber. I get down to the bottom of the steps, and I start evidently looking weird, and [the people I was with] were like, “Are you okay?”
She continued: “I drank all this water. I leave my house. And they kept asking me, ‘Do you want coffee?’ And I was like, ‘No.’ ‘Are you all right?’ I go, ‘Yeah, great.’ Then I walked to the corner—no reason at all. I’m like, ‘Why am I out here?’ Then I walk into the restaurant L’Artusi, and I go to the sommelier who had just taken an hour to watch my run-through.”
At this point, she said everything went black, her hands dropped to her side and she went headfirst into the wall. Shields said that she was frothing at the mouth with a blue face and trying to swallow her tongue before being loaded into an ambulance with an oxygen mask on.
Notably, this grand mal seizure, which affects 25% of all patients with seizures, took place next to Oscar-nominated actor Bradley Cooper.
Shields is fine now and said doctors eventually determined that she had low sodium and drank too much water, basically flooding her system and “drowning” herself to the point that it induced a seizure.
Obviously a scary scene for Brooke Shields. We’re glad that she’s feeling better. Obviously. She’s had a number of Health scares over the years. But you know, I give her credit for being open with something that admittedly we don’t really talk a lot about do we Usha?
Yeah. I mean, you know, I feel like we we get a different celebrity every week on this podcast who you know shines a light on a rare and unusual medical issue. And this is definitely one of them you tend to hear about how people aren’t drinking enough water usually and like dehydration issues, you know, but it is the real emergency. If you get to the point of drinking too much water according to the Mayo Clinic, it’s not common. It’s rarely a problem for your average healthy adults, but it can be an issue among athletes. For example, if they’re trying to drink excess fluids during workouts.
Too much water intake results in your kidneys not being able to get rid of it your sodium content in your bloodstream becomes diluted and it’s a condition called hyponatremia, and it is life-threatening. So good to hear that Shields was able to recover and you know, just a reminder to continue drinking your your eight glasses of water a day, but definitely don’t overdo it.
Yeah, I agree with you less sure. That one usually hears the opposite with regard to water intake and it’s interesting in terms of the way a person can can fulfill that it’s glasses daily requirements. You can get through coffee through juice anything basically that includes water in it, but I’m acknowledging my ignorance on this one. I was surprised to read how common nutrimi is in both in patients and outpatients according to the medical literature, but Shields revealing that she already had low sodium levels at the time. She was consuming lots of water which is obviously dangerous combination made her perhaps more susceptible to this if one
As kidney problems that would be another example where excreting excess water could be an issue and the system can become overwhelmed but for most of us, it’s just making sure like you said we’re staying within that normal range and the Cleveland Clinic notes that adding salt to the diet is another way to manage the hyponatremia. So I would suggest pretzels
it mentions in the story too that her doctors basically said you have to eat more potato chips, which if that’s the sentence that you have to get. There are worse. There are worse Medical Treatments in my book.
There are turmeric face masks, “skinimalism” routines, slugging, facial flooding and many more skincare trends. TikTok has an obsession with skincare, but medical experts have a few concerns.
Some of the top videos on the app fall under the #skincare hashtag and have gathered more than 25 million views. The amount of information about skincare products – from retinol to hyaluronic acid to Vitamin C – can be overwhelming at times.
TikTok’s preoccupation with achieving the perfect skin is far bigger than any one single trend. Still, in users’ ongoing quests to perfect their skincare routines, some questionable trends – and scores of claims and misinformation about dermatology – appear.
Some of the sketchier trends include eating a spoonful of vaseline every day for better skin.
In addition, as young people experiment with skin products, they position themselves as experts in the field, posting videos to instruct others on how to take care of their skin.
Dermatologists and other medical experts are now competing with the fountain of skincare content on TikTok, including the influencers who may arguably hold more sway over young patients than themselves.
In response to TikTok’s skincare obsession, some healthcare professionals have sought to cut through the noise and reach those audiences. The Cleveland Clinic, for example, has put out a blog post responding to different TikTok trends, with medical experts offering guidance on what trends can be useful, which ones are totally unnecessary – and which ones can be flat-out dangerous.
I’ll take a first stab at it less I think and and I always want to know that there’s always a line that Lesha includes in any of these stories about social media and when I got to eating a spoonful of Vaseline, that was the first one where I got that just this visceral cringe, but it is a challenge I would I would say that it’s probably a real priority for the listeners and our audience that are you know on the agency side or Market these products to say
It’s already competitive enough going against your Rivals and your opponents on a day-to-day basis. But when you’re then trying to reach consumers who are you know, taking any sort of advice they get from an influencer whether that’s a major influencer or a micro influencer who maybe they have more of a trusted relationship with I don’t know how you necessarily breakthrough that I think you everyone always says, you know more information more reliable information more trusted information and communicating that across but that’s got to be an issue when the playing field is so different than what it was years ago. I know that skincare is always kind of been touching going in terms of different Trends and fads and stuff like that. But this one seems, you know, particularly Troublesome in terms of maybe some of the more dangerous ones out there.
What do you think Mark? Hey, you know, we did a round table recently on digital transformation and Pharma of all topics, but we happen to have some participants there from one of the aesthetic companies whose name I won’t mention but you know, we were talking about this area of influencers.
And they made a great point that in plastic surgery the plastic surgeons become just as influential as anybody and they developed their own followings.
Often times we’ve seen their marketing. It’s oftentimes a different breed than the typical RX branded Marketing in terms of you know, they they really hold a lot of sway, you know what their patients their patients look to them for aesthetic advice and then when it comes to say going under the knife or using Botox or whatever it might be a lot of them are, you know, obviously take a lot of care in their own appearance and and it really, you know, helps them to cut through that noise, you know with bona fide medically evidence backed information. And so I’m sure Dermatology this is not lost on many dermatologists who sort of also kind of straddle that line into you know, where it becomes sort of aesthetic and mix mix of you know, aesthetic and medical but you know where I’m going with this is I guess dermatologist would need to become more like their classic Surge and counterparts in terms of, you know, developing that Following being more.
Or you know aggressive in terms of injecting evidence-based advice into this comment stream or doing their own tiktoks. And unless you you point out some dermatologists in your story so that I guess that trend is already a foot but perhaps it’s nascent and just needs to become more prominent for.
This pancreatic cancer research fund was launched last week with more than $1 million in contributions.
Stand Up To Cancer and Jean Trebek, the widow of longtime Jeopardy! host, recently launched the fund to support research into a major cancer with one of the highest mortality rates.
Trebek and the estate of Barbara Hanania have donated more than $1 million to the cause and SU2C will be fundraising throughout November, which is Pancreatic Cancer Awareness Month.
Readers will recall that Trebek hosted Jeopardy! from 1984 to 2020 and spent the last year or so of his life battling pancreatic cancer. A beloved part of American TV, Trebek was public with his battle with the disease and through this namesake fund, will continue to make an impact on the lives of patients.
I don’t know if you are a lifelong fan of Jeopardy like myself, but obviously I remember when Alex was diagnosed and obviously, you know the stories and the reporting that came out during his battle and brought a lot of attention to pancreatic research and it’s really encouraging that through this fun. He’ll be able to do the same thing going forward.
Yeah, you know, it’s it’s always good to hear when celebrities have a positive influence and unhealthcare as we’ve discussed many times before and in light of this being pancreatic cancer awareness month. I actually did an interview last week for a separate story Jack. I’m working on related to pancreat pancreatic cancer awareness month with a pain creative cancer survivor and Advocate who really mention that you know actually tends to be a little harder to shine a spotlight on pancreatic cancer.
Particular compared to other more common cancers like breast cancer, for example pancreatic cancer ranks around 12th in the list of most common cancers. So it’s probably not often as talked about as other types of cancer, you know, so it’s always it’s always good to hear when celebrities are able to use their influence to move forward cancer awareness or funds and donations and it’ll be interesting to see what other initiate initiatives pop up during pancreatic Awareness Month.
Absolutely and just to add another observation. You know, I see a lot of parallels here with the movement toward a lot of disease research being funded by the patient Community overall, you know, I think groups like Nord our track have seen a huge spike in you know funding for research coming from the patient advocacy community and you know funds like this and so this type of thing now, it’s Rebecca pancreatic.
Research fund I think kind of highlights that Trend, you know of, you know, this kind of Grassroots movements which kind of alongside the traditional route which is you know, bio-farma sponsoring clinical trials is really coming into its own, you know, and in terms of a real driving force for areas that have historically been neglected and that could use more attention and pancreatic cancer certainly no exception. So great great to see this effort get started here.
Thanks for joining us on this week’s episode of the MM+M Podcast. Be sure to listen to next week’s episode when we’ll be joined by Trinity Life Sciences CEO Leslie Orne.
“As you can imagine, many of Tiktok’s skin care tips are not the ones your doctor would recommend,” the Clinic noted. “Some are harmless but ultimately unnecessary, while others are actually very dangerous.”
Skincare is one of those TikTok topics that’s so vast and overwhelming that users really do have to learn how to cut through the noise. Obviously reaching the audiences of TikTok has been a big issue for HCPs. Curious if either of you have thoughts on how HCPs can work to handle something like this, competing with influencers.
;
